LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (AMEX:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, unveiled a powerful new molecular design capability at the American Chemical Society national meeting in Chicago last week.
